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 Abstract 
 
Objective: The objective of this selective EBM review is to determine whether or not Ayurvedic 
is effective in reducing osteoarthritis pain in adults. 
 
Study Design: Review of three English language randomized controlled trials published 
between from 2004-2013. 
 
Data Sources: Two double blind randomized controlled trials and one open label randomized 
controlled clinical trial were found using PubMed and Cochrane Library databases.  
 
Outcomes Measured: To measure the effectiveness, the following parameters were utilized 
visual analog scale (VAS) reported by the patient to assess reduction in pain symptoms of 
osteoarthritis. 
 
Results: Three randomized controlled studies results found that Ayurvedic medicine was 
beneficial in providing symptomatic pain relief in patients of osteoarthritis in adults. 
 
Conclusions: The results of all three selected studies in this systemic review demonstrated that 
Ayurvedic provides some effectiveness in reducing osteoarthritis pain in adults when compared 
to conventional medications used for osteoarthritis.  
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INTRODUCTION 
 Osteoarthritis is the most common type of arthritic disease, causing degenerative changes 
to the joints from everyday “wear and tear,” causing disability, pain and loss of function.3,4  This 
paper evaluates two double blind, randomized controlled clinical trials and an open label 
randomized controlled clinical trial comparing the efficacy of Ayurveda.  For many centuries, in 
Eastern medicine, herbs have been used manage and treat osteoarthritis as an alternative form 
using conventional medicine.  Ayurveda is a popular herbomineral drug in the Indian 
subcontinent that utilizes a holistic approach for alleviating symptoms of osteoarthritis pain in 
adults.
1,2
   
 Approximately 27 million people in the United States have osteoarthritis.  It is the 
leading cause of disability in non-institutionalized adults.
4,5
  Both incidence and prevalence of 
osteoarthritis are on the rise due to increasing age and obesity.
5
  Due to the growing populations 
that are effected with osteoarthritis it has a become a financial burden on both the healthcare 
system and patient population.  The estimated average patient’s out of pocket cost is $2,600 per 
year.
4   
Osteoarthritis accounts for 69.9% of all arthritis-related hospitalizations.
4
 
 Osteoarthritis develops gradually; however there are unknown parameters of causes, 
which contribute to degenerative changes resulting in an overall arthritic disease state of the 
joints.
5
  
 
Osteoarthritis is characterized with following symptoms: pain, swelling, and stiffness, 
loss of flexibility, grating sensation, and development of bone spurs noted in radiographic 
images.
6
 
 The management of osteoarthritis requires a multidisciplinary approarch.
3
  The use of 
acetaminophen, NSAIDs, narcotics, cortisone injections, engaging in physical and occupational 
therapy, exercise, proper weight management, and surgical options such as bone realignment and 
joint replacements can all help improve symptoms of osteoarthritis.
1,2,3
  Currently, there is no 
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cure for osteoarthritis; the above methods are utilized to help alleviate the symptoms of 
osteoarthritis.
4
  Due to its popular use in Eastern medicine and the growing trend for using herbal 
remedies, it is believed that Ayurveda may provide an alternative method of relief for 
osteoarthritis symptoms. 
OBJECTIVE 
 The objective of this selective EBM review is to determine whether or not Ayurvedic is 
effective in reducing osteoarthritis pain in adults. 
METHODS  
The criteria used for the selections of studies included the population of adult patients with 
osteoarthritis diagnoses with radiographic changes and an intervention of Ayurvedic medicine, 
with comparisons made with common conventional treatments such as nonsteroidal anti-
inflammatory drugs (NSAIDs), Celecoxib, and Diclofenac.  The outcomes measured were 
reduction and improvement pain symptoms of osteoarthritis.  The studies utilized in this systemic 
review included three randomized controlled trials, specifically two double blind randomized 
controlled clinical trials and one open label randomized controlled clinical trial.    
The selections of this systemic review included a literature search using the Cochrane 
Library and PubMed databases and were limited search to the following keywords: “Ayurvedic 
medicine”, “Ayurveda”, and “osteoarthritis.”  All articles were written in English and published 
in peer-reviewed journals between the years 2004 and 2013.  All articles that were selected for 
this systemic review are based on their relevance to the topic and on the patient-oriented 
outcomes (POEMs).  Inclusion criteria included that the studies selected for this systemic review 
were randomized controlled and either double blind or open label, adult patients with 
osteoarthritis pain with radiographic changes.  Exclusion criteria included those patients less than 
18 years of age, pregnant or lactating women.  Table 1 outlines the demographics and 
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characteristics of the selected studies used in this systemic review.  The statistics reported in the 
selected studies were p-values, confidence intervals (CI), ANOVA, and unpaired T-test.  
 
Table 1 - Demographics & Characteristics of included studies  
Study Type # pts Age Inclusion Criteria Exclusion Criteria W/D Intervention 
Chopra
1 
(2004) 
Randomized 
controlled 
trial (double-
blind) 
 
358 >35 
yrs 
OA of knee 
classified via ACR 
and radiologic 
criteria.  
VAS > 40 mm.  
Patient on a stable 
dose of a NSAID. 
Female patients of 
child-bearing 
potential only if 
practicing 
contraception. 
 
Pregnant or 
lactating women. 
Hx uncontrolled 
medical disease or 
abnormal renal 
and hepatic 
function. 
Received intra-
articular 
corticosteroid 
injections in the 
knee joint within 
3 months. 
Hypersensitivity 
to RA-11 or its 
components. 
28 RA-11 
(ARTREX, 
MENDAR) 
2 capsules BID  
 
Chopra
2 
(2013) 
Randomized 
controlled 
trial (double-
blind) 
440 40-
70 
yrs 
Diagnosis of knee 
OA with the ACR 
criteria.  VAS score 
of 54 cm in one or 
both knees.  
Ambulant patients 
that required 
frequent analgesics.  
 
Pregnant or 
lactating or 
women. 
Hx of non-DJD, 
severe disabling 
arthritis or spine 
and lower limb 
surgery, peptic 
ulcer bleed, or 
any unstable 
severe medical 
disease. 
Patients on 
medication that 
may influence 
efficacy 
evaluation. 
123 Ayurvedic  
(SGCG) 
400mg, 2 
capsules TID 
 
Ayurvedic SGC 
400mg, 2 
capsules TID 
 
Pengkhum
3
 
(2012) 
Randomized 
controlled 
trial (open 
label) 
 
60 >50 
yrs 
OA diagnosed with 
radiographs and 
assessed by the 
Kellgren et al 
grading system. 
Patients using 
Hx of severe RA 
inflammatory 
arthropathy, 
recent knee injury 
or received intra-
articular 
9 Ayurved Siriraj 
Wattana Recipe 
900 mg/day 
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acetaminophen for 
the most painful 
knee movement 
assessed by a VAS 
>4. 
treatment. 
Patients that were 
expectation of 
future surgery. 
 
OUTCOMES MEASUERED 
 Outcomes measured in the selected studies were based on patient-oriented outcomes 
(POEMs) of reduction in pain symptoms of osteoarthritis, at rest and during weight bearing 
activities.  These outcomes were measure via the visual analog scale (VAS), the Western Ontario 
and McMaster Universities Osteoarthritis Index (WOMAC), the Oxford-12, and global 
assessment by both the patients and physicians in the selected studies.   
 Both studies conducted by A. Chropra et al. utilized the visual analog scale, and 
WOMAC questionnaire to assess knee and/or hip pain in osteoarthritis patients.  VAS assessed 
active pain on body weight-bearing activity, such as walking, and at rest of subjects with scores 
ranging from 0 for no pain and 10 for maximum pain.   
 Pengkhum et al. utilized the Oxford-12 questionnaire and the VAS for the assessment of 
function and pain of the knee in osteoarthritis patients judged by the patient.  The VAS assessed 
pain during the most painful knee movement.  
RESULTS 
 In the selected study conducted by Chopra et al. (2004) assessing the RA-11 (Ayurvedic) 
compared to a placebo taken twice a day after meals, in the treatment of patients with 
osteoarthritis of the knees.  The study design was a randomized, double-blind, parallel efficacy 
and placebo-controlled trial for the duration of 32 weeks.  Overall 90 subjects participated in the 
study and were randomly assigned that received the allocated treatments described above, and 
there were no significant difference between the groups. The study evaluation was made at 
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baseline and every week until completion of 32 weeks.  Total of 28 subjects withdrew from trial. 
The study was presented in continuous data and intention to treat with the last observation 
carried out using analysis of variance (ANOVA).  Active pain VAS and WOMAC pain were 
used to compare the two groups, with the focus on active pain VAS for RA-11 comparison to the 
placebo control demonstrated by Table 2.
1
  The mean change in efficacy was measured at week 
16 displaying the VAS for pain, for RA-11 -2.68 and placebo -1.30, with a p-value of 0.000 and 
for week 32, RA-11 -2.83 and placebo -1.80, with a p-value of 0.034, due to a plateau-like effect 
as the trial progressed.  
Table 2: Mean change in efficacy at week 16 and week 32 (Mean and SD) from Chopra et al. 
(2004) 
Variable e Week 16 Treatment Week 32 Treatment 
 
 
VAS for pain 
Active  Placebo P* 
-2.68, 
(+/-
0.29) 
-1.30, 
(+/- 
0.31) 
0.000 
 
Active  Placebo P* 
-2.83 
(+/-
0.38) 
-1.86, 
(+/- 
0.36) 
0.034 
 
     P* analysis of variance. 
 In the selected study conducted by Chopra et al. (2013) compared two standard 
Ayurvedic formulations (SGCG and SGC) to glucosamine (2 g daily) and Celecoxib (200 mg 
daily) which were given two capsules three times a day with plain water to assess effectiveness.  
SGCS formulation contained an additional plant extract, B. serrata allowing it to be of higher 
potency, which was not found in the SGC formulation of the Ayurvedic medicine.  The study 
design was a randomized double-blind for the duration of 24 weeks.  The study evaluation was 
made at baseline and weeks 2, 4, 8, 12, 16, 20 and 24.  Overall 440 subjects participated in the 
study and were randomly assigned into four groups of 110 participants that received the allocated 
treatments described above, and there were no significant difference between the groups.  Total 
of 126 (28.6%) subjects withdrew from trial.  The study was presented in continuous data and 
intention to treat with the last observation carried out using analysis of variance (ANOVA).  
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Active pain VAS and WOMAC pain were used to compare the four groups, with the focus on 
active pain VAS for SGCS comparison to Celecoxib.  Efficacy calculated that mean change of 
active body weight-bearing pain VAS from baseline to completion was fairly small for SGCG is 
-2.04 (CI 95%  -2.47, -1.61) compared to Celecoxib is -1.82 (CI 95% -2.20, -1.44).  The p-value 
is calculated at 0.21 indicating not statistically significant between SGCG and Celecoxib, as 
demonstrated by Table 3.
2 
Table 3: Efficacy from baseline to completion intent-to-treat analysis from Chopra et al. (2013) 
 SGCS (Ayurvedic 
medicine) 
Celecoxib P 
(comparison, 
ANOVA) 
Active pain VAS 
(mean change) 
-2.04 (CI 95% -2.47, -1.61) -1.82 (CI 95% -2.20, -1.44) 0.21 
 
 In the selected study conducted by Pengkhum et al. assessed the use of Ayurved Siriraj 
Wattana recipe (900 mg/day) comparing it with Diclofenac (75 mg/day), for providing 
symptomatic relief in patients with osteoarthritis of the knee.  The study design was randomized, 
open-label, NSAIDs controlled trial for the duration of 12 weeks. Overall, there were 60 subjects 
participated in the study and were equally divided and randomly assigned to a treatment group. It 
was reported that 27 patients (90%) in Ayurved Siriraj Wattana recipe group and 24 patients 
(80%) in Diclofenac group completed the study, thus nine patients withdrew from the study.  The 
study was presented in continuous data and statistical significant was evaluated by using 
unpaired T-test. VAS was utilized to assess the reduction in pain when Ayurved Siriraj Wattana 
recipe and Diclofenac are used at 2, 4, 8, and 12 weeks, as demonstrated by Table 4.  On week 
12, efficacy was calculated for VAS assessed pain the mean change for Ayurved Siriraj Wattana 
recipe at 4.37 compared to Diclofenac 4.42 as small, with the p-value calculated at 0.94 
indicating not statistically significant.
3
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Table 4: Efficacy at baseline and follow-up visits from Pengkhum et al. (2012)  
VAS assessed pain Wattana 
(mean) 
Diclofenac 
(mean) 
95% CI p-value 
Baseline 6.63 6.58 -0.899, 0.807 0.91 
Week 2 5.93 5.17 -1.594, 0.075 0.07 
Week 4 5.48 5.58 -0.693, 0.896 0.79 
Week 8 4.89 4.25 -1.568, 0.291 0.17 
Week 12 4.37 4.42 -0.909, 0.973 0.94 
 
 For all three selected studies safety and tolerability of each intervention was measured via 
number of adverse events during each trial and recorded. Table 5 shows the overall adverse 
effects that result in Number Needed Harm (NNH) for the selected studies. 
Table 5: Adverse Effects that result in NNH for the selected studies 
Study Ayurvedic 
Medicine’s 
AE (%) 
Placebo or 
Comparison 
Drug’s AE (%) 
RRI(%) ARI(%) NNH 
Chopra
1 
(2004) 
27.7 26.5 4.5 1.2 83 
Chopra
2 
(2013) 
28.16 32.38 12.9 4.2 24 
Pengkhum
3
 
(2012) 
6.6 9.9 33.3 3.3 30 
 
DISCUSSUION 
Osteoarthritis is chronic condition that causes a wide range of problems in many patient 
population, and current conventional medication used have adverse side effects associated with 
them.  Therefore, the goal of Ayurvedic medicine is to provide symptomatic relief from 
osteoarthritis pain.  
Limitations exist in all the selected studies.  The limitations of the selected studies are as 
follows: various formulations of Ayurvedic medicine were utilized, the studies used different 
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dosages, only Asian decent subjects participated in the study, and it is hypothesized that 
Ayurevedic medicine is considered safe, because of its long history of use in the Eastern culture 
but with limited evidence support.  Specifically, Chopra et al. (2004) researchers were unable to 
explain the precise reason for the strong placebo response and a large number of patients 
withdrew from the study, Chopra et al. (2013) used a large number of participants (440) which 
would be harder to assess efficacy and follow-up, and  Pengkhum et al. mostly females were 
enrolled in the study.
1,2,3
  Due to these limitations, there is a need for more research to be 
conducted to warrant the effectiveness of Ayurvedic medicine in reducing osteoarthritis pain in 
adults.  
CONCLUSION 
 This systemic review investigated three studies of randomized control trials that 
demonstrated the effectiveness of Ayurvedic medicine used for managing pain in adults patients 
with osteoarthritis.  The selected studies for this systemic review demonstrated Ayurvedic 
medicine is effective when compared to conventional treatments, such as Celecoxib and 
Diclofenac, and is statistical significant when compared to placebo.
1,2,3
  Ayurvedic medicine has 
been used for centuries and provides patients of osteoarthritis an alternative therapeutic option 
which can help decrease the side-effects of NSAIDs, such as gastrointestinal ulcers and co-
morbidities.  Future studies need to be conducted to determine the efficacy of Ayurvedic 
medicine in osteoarthritis patients, which are open globally and assess subjects from all origins 
to assess if Ayurvedic medicine is effective in reducing osteoarthritis pain in adults. 
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